Trxade Group, Inc. Pharmacy Customer Network Grows to 5,000

TAMPA, Fla., Dec. 2, 2015 (GLOBE NEWSWIRE) -- Trxade Group, Inc., (OTCQB:TRXD) a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced today that it added 400 new customers to its network of independent pharmacy users, bringing the total to 5,000 pharmacies.

Trxade's Supplier-to-Pharmacy (S2P) web-based service enables pharmacies to compare prices for and purchase pharmaceutical products from a wide number of pharmaceutical wholesalers from a single point. Without S2P, if pharmacies want to compare prices from multiple suppliers, they need to search prices from each supplier individually – a time-consuming process. S2P brings pricing transparency, supplier price competition and simplifies the purchasing process for pharmacy customers saving time as well as costs. Trxade's web platform also includes pharmacy-to-pharmacy trading capabilities (P2P) to help customers monetize their overstocked inventories.

"We are proud of reaching this important customer milestone," commented Suren Ajjarapu, Trxade's Chairman and Chief Executive Officer. "Since June, we have grown our customer base by over 40%. Over the next few years our goal is to grow revenues flowing through our platform by increasing the number of pharmacies using our services as well as the amount of purchasing done through our platform. With 24,000 independent pharmacies in the U.S. accounting for $93 billion in pharmaceutical purchases each year, we believe we have tremendous growth potential ahead of us."

About Trxade Group, Inc.

Headquartered in Tampa, Florida, Trxade Group, Inc. is a web based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services. Founded in 2010, Trxade Group currently operates the trading platform with 5,000 registered members. Trxade Group also distributes directly private label pharmaceuticals through their 100% subsidiary Westminster Pharmaceuticals to these registered members. For additional information please visit us at

Disclaimer & Forward-Looking Statements

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements.

Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. Except as may be required by applicable law, we assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The company undertakes no duty to update forward-looking statements.

CONTACT: Investor Relations Contact: Max Pashman Phone: 818-280-6800

Source:Trxade Group, Inc.